Paper
0
Efficacy, durability, and response predictors of low-dose interleukin-2 therapy for chronic graft-versus-host disease
Authors
Journal
Published
Apr 13, 2016
Show more
Save
Tip0
TipSave
Abstract
Paper PDF
This paper's license is marked as closed access or non-commercial and cannot be viewed on ResearchHub. Visit the paper's external site.